Azitra (AZTR) Tax Provisions (2023 - 2025)

Azitra (AZTR) reported Tax Provisions of $8319.0 for Q4 2025, down 7.88% on a YoY basis from $9031.0 in Q4 2024, and down 7.88% quarter-over-quarter from $9031.0 in Q4 2024.

Azitra (AZTR) Tax Provisions (2023 - 2025) Analysis & Trends

Azitra has reported Tax Provisions for 3 years, with the latest figure at $8319.0 in Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions fell 7.88% year-over-year to $8319.0; the trailing twelve-month figure through Mar 2026 stood at $8319.0 (down 7.88% YoY), and the FY2025 full-year result was $8319.0, down 7.88% from the prior year.
  • Tax Provisions for Q4 2025 stood at $8319.0, down from $9031.0 in the prior quarter.
  • The five-year high for Tax Provisions was $9715.0 in Q1 2023, with the low at $7593.0 in Q4 2023.
  • Historically, Tax Provisions has averaged $8664.5 across 3 years, with a median of $8675.0 in 2024.
  • Annual changes were most pronounced in 2024 — Tax Provisions advanced 18.94% — and 2025, when it dropped 7.88%.
  • Azitra's Tax Provisions stood at $7593.0 in 2023, then increased by 18.94% to $9031.0 in 2024, then retreated by 7.88% to $8319.0 in 2025.
  • The last three Tax Provisions figures came in at $8319.0 (Q4 2025), $9031.0 (Q4 2024), and $7593.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -11.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 216,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -859,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 221.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Azitra 20,900.00 20,900.00 - -

Historic Data

Download Data
DateValue
Dec 31, 2025 8,319.00
Dec 31, 2024 9,031.00
Dec 31, 2023 7,593.00
Mar 31, 2023 9,715.00